A detailed history of Allworth Financial LP transactions in Glaukos Corp stock. As of the latest transaction made, Allworth Financial LP holds 52 shares of GKOS stock, worth $7,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 64 18.75%
Holding current value
$7,845
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$113.62 - $135.39 $1,363 - $1,624
-12 Reduced 18.75%
52 $6,000
Q2 2024

Jul 23, 2024

BUY
$89.48 - $118.35 $2,952 - $3,905
33 Added 106.45%
64 $7,000
Q1 2024

Apr 25, 2024

SELL
$76.4 - $96.33 $229 - $288
-3 Reduced 8.82%
31 $2,000
Q3 2023

Oct 31, 2023

BUY
$69.23 - $79.09 $2,146 - $2,451
31 Added 1033.33%
34 $2,000
Q4 2022

Jan 13, 2023

SELL
$40.82 - $57.75 $612 - $866
-15 Reduced 83.33%
3 $0
Q3 2022

Oct 18, 2022

BUY
$46.84 - $58.49 $702 - $877
15 Added 500.0%
18 $1,000
Q2 2022

Jul 13, 2022

BUY
$34.86 - $63.77 $104 - $191
3 New
3 $0

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.